Drugs / Flufirvitide 3
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01990846 | Mar 2014 → Feb 2015 | influenza | Autoimmune Technologies, LLC | Completed | No outcome recorded |
| Phase 1 | NCT01313962 | Aug 2011 → Jan 2012 | influenza | Autoimmune Technologies, LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Flufirvitide 3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01990846 ↗ |
| Route | Intranasal | “Nasal Spray” NCT01313962 ↗ |